Mikazust 500 Injection
Marketer
Zenotis Healthcare
Salt Composition
Amikacin (500mg)
Overview Mikazust 500 Injection
Cefazolin 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized individuals. Its mechanism involves inhibiting bacterial proliferation. Administration, strictly by a healthcare professional, involves intravenous infusion or direct intramuscular/intravenous injection. Consistent, evenly-spaced dosing, as prescribed, is crucial. Complete the prescribed regimen; premature cessation risks relapse or infection exacerbation. Typical adverse reactions involve injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness necessitate consultation. High doses may rarely induce vertigo, renal impairment, and auditory deficits. Strict adherence to physician instructions is paramount, potentially including kidney function, hearing, and urine analyses. Pregnancy contraindicates its use; inform your doctor of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Mikazust 500 Injection
Infections caused by bacteria
Major Benefits of Mikazust 500 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikazust 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikazust 500 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mikazust 500 Injection works:
Kazamycin 500 Injection, an antibacterial agent, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Mikazust 500 Injection poses no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikazust 500 Injection during pregnancy poses a confirmed risk to the fetus. Its use should be strictly avoided except in potentially fatal circumstances where the physician deems the potential benefits outweigh the known hazards. Always seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
Mikazust 500 Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Mikazust 500 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Mikazust 500 Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikazust 500 Injection appears to pose minimal risk for individuals with hepatic impairment. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mikazust 500 Injection :
Omit a Mikazust 500 Injection dose? Seek your physician's advice.
Facts to Know About Mikazust 500 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently